1. OP0086 Long-term efficacy and safety of adalimumab by immunosuppressant use in patients with non-infectious uveitis in the visual iii trial. (12th June 2018) Authors: Guex-Crosier, Y.; Foster, C.S.; Nakai, K.; Goto, H.; Douglas, K.; Pathai, S.; Kron, M.; Song, A.P.; Van Calster, J.; Adán, A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0590 Long-term efficacy and safety of adalimumab by aetiologyin patients with non-infectious uveitis in the visual iii trial. (12th June 2018) Authors: Merrill, P.T.; Vitale, A.; Zierhut, M.; Fortin, E.; Goto, H.; Kron, M.; Song, A.; Douglas, K.; Pathai, S. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0583 Quiescence in Active and Inactive Non-Infectious, Intermediate, Posterior, or Panuveitis in Patients Treated with Adalimumab: Visual I and Visual II Trials. (15th July 2016) Authors: Landewe, R.; van der Horst-Bruinsma, I.; Tari, S.; Florentinus, S.; Song, A.; Kron, M.; Pathai, S.; Rosenbaum, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗